Carcinoma, Lewis Lung
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals2
- Cancer research1
- Nature communications1
Leading researchers8
- Antonia S1
- Behrens C1
- Brayer J1
- Byers LA1
- Chapman HA1
- Chen L1
- Correa P1
- Cuentes ERP1
Affiliations (unnormalised)4
- Stanley S. Scott Cancer Center1
- The University of Texas MD Anderson Cancer Center1
- UCSF Cardiovascular Research Institute1
- University of North Carolina at Chapel Hill1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.